Search results for "Neuropsychological assessment"

showing 10 items of 67 documents

Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative rol…

2019

Anorexia nervosa (AN) is a severe eating disorder accompanied by alterations in endocrinological circuits and deficits in neuropsychological performance. In this study, a series of appetite-regulating hormones (ghrelin, leptin, cholecystokinin, PYY, adiponectin, and visfatin) were measured under fasting conditions in female patients with AN and female healthy controls. All of the participants also underwent a battery of neuropsychological assessment [namely the Iowa Gambling Task (IGT), the Wisconsin Card Sorting Test (WCST), and the Stroop Color and Word Test (SCWT)]. As the main finding, we found that higher ghrelin levels predict better performance in the IGT. Ghrelin may be a putative m…

0301 basic medicineAdultmedicine.medical_specialtyAnorexia Nervosamedia_common.quotation_subjectDecision MakingAppetite030209 endocrinology & metabolismNeuropsychological TestsBiochemistryModels BiologicalCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineEndocrinologyWisconsin Card Sorting TestInternal medicineAppetite regulationmedicineHumansNeuropsychological assessmentMolecular Biologymedia_commonmedicine.diagnostic_testbusiness.industryLeptindigestive oral and skin physiologyAppetiteAnorexia nervosaIowa gambling taskNeuropsychological performanceGhrelin030104 developmental biologyEndocrinologyAnorexia nervosa (differential diagnoses)Case-Control StudiesGhrelinbusinesshormones hormone substitutes and hormone antagonistsStroop effectDecision-making
researchProduct

Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study.

2018

Background: Cognitive impairment in Parkinson's disease (PD) includes a spectrum varying from Mild Cognitive Impairment (PD-MCI) to PD Dementia (PDD). The main aim of the present study is to evaluate the incidence of PD-MCI, its rate of progression to dementia, and to identify demographic and clinical characteristics which predict cognitive impairment in PD patients. Methods: PD patients from a large hospital-based cohort who underwent at least two comprehensive neuropsychological evaluations were retrospectively enrolled in the study. PD-MCI and PDD were diagnosed according to the Movement Disorder Society criteria. Incidence rates of PD-MCI and PDD were estimated. Clinical and demographic…

0301 basic medicineAgingmedicine.medical_specialtyParkinson's diseaseCognitive NeuroscienceParkinson's diseasebehavioral disciplines and activitieslcsh:RC321-57103 medical and health sciences0302 clinical medicinemild cognitive impairmentInternal medicinemental disordersMedicineDementiaNeuropsychological assessmentMild cognitive impairment (MCI)lcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal Researchmedicine.diagnostic_testbusiness.industryProportional hazards modelIncidence (epidemiology)Neuropsychologymedicine.diseasenervous system diseasesneuropsychological assessment030104 developmental biologyCohortParkinson’s diseaseincidencebusiness030217 neurology & neurosurgeryNeurosciencedementiaFrontiers in aging neuroscience
researchProduct

Heterozygous deletion of the LRFN2 gene is associated with working memory deficits

2016

International audience; Learning disabilities (LDs) are a clinically and genetically heterogeneous group of diseases. Array-CGH and high-throughput sequencing have dramatically expanded the number of genes implicated in isolated intellectual disabilities and LDs, highlighting the implication of neuron-specific post-mitotic transcription factors and synaptic proteins as candidate genes. We report a unique family diagnosed with autosomal dominant learning disability and a 6p21 microdeletion segregating in three patients. The 870 kb microdeletion encompassed the brain-expressed gene LRFN2, which encodes for a synaptic cell adhesion molecule. Neuropsychological assessment identified selective w…

0301 basic medicineMaleCandidate genefamilyspeechHippocampal formationRats Sprague-Dawley0302 clinical medicineBorderline intellectual functioningNeuropsychological assessmentChilddisordersGenetics (clinical)Cells Culturedadhesion-like moleculesMembrane Glycoproteinsmedicine.diagnostic_testLearning DisabilitiesBrainMagnetic Resonance Imaging3. Good healthPedigreeMemory Short-TermBrain sizeFemaleAdultHeterozygotenmda receptorautismNerve Tissue ProteinsBiologyReceptors N-Methyl-D-AspartateArticle03 medical and health sciencesFluorodeoxyglucose F18[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyexpressionGeneticsmedicineAnimalsHumansMemory DisorderslanguageGenetic heterogeneityWorking memoryMembrane Proteinsdown-syndromeRats030104 developmental biologyEndophenotypePositron-Emission TomographySynapsesshort-termRadiopharmaceuticalsNeuroscience030217 neurology & neurosurgeryGene Deletion[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Mild behavioral impairment in Parkinson's disease: Data from the Parkinson's disease cognitive impairment study (PACOS)

2019

Neuropsychiatric symptoms (NPS) have been frequently described in Parkinson's disease (PD), even in the earliest stages of the disease. Recently the construct of mild behavioral impairment (MBI) has been proposed as an at-risk state for incident cognitive decline and dementia. The aim of the present study is to evaluate the prevalence and associated factors of MBI in PD. Cross-sectional data from 429 consecutive PD patients enrolled in the PArkinson's disease COgnitive impairment Study (PACOS) were included in the study. All subjects underwent neuropsychological assessment, according to the MDS Level II criteria. NPS were evaluated with the Neuropsychiatric Inventory. Multivariate logistic …

0301 basic medicineMalemedicine.medical_specialtyParkinson's diseaseParkinson's diseaseMild behavioral impairmentNeuropsychiatric symptomDiseaseCognitive impairment; Mild behavioral impairment; Neuropsychiatric symptoms; Parkinson's disease; Prevalence; Neuroscience (all); Clinical Psychology; Geriatrics and Gerontology; Psychiatry and Mental HealthNeuropsychological TestsLogistic regressionSeverity of Illness Index03 medical and health sciences0302 clinical medicineInternal medicinemedicinePrevalenceDementiaHumansCognitive DysfunctionNeuropsychological assessmentCognitive declineStage (cooking)Cognitive impairmentAgedNeuroscience (all)medicine.diagnostic_testbusiness.industryGeneral NeuroscienceParkinson DiseaseGeneral MedicineMiddle Agedmedicine.diseaseNeuropsychiatric symptomsClinical Psychology030104 developmental biologyCross-Sectional StudiesCognitive impairmentPsychiatry and Mental HealthFemaleGeriatrics and Gerontologybusiness030217 neurology & neurosurgery
researchProduct

Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia?

1992

The Wisconsin Card Sorting Test (WCST) is a neuropsychological test, hypothesized to be an indicator of dorsolateral prefrontal cortex (DLPFC) functioning. The performance of schizophrenic patients in our sample (off medication) was worse than the performance of healthy controls in all variables of the WCST, including perseverative responses (PR) as well as non-perseverative responses (NPR). The rate of perseverative and non-perseverative responses was neither a function of the severity of the illness (measured by SANS/SAPS scales) nor the duration of the disease. Healthy siblings of schizophrenic probands revealed more perseverative responses than healthy controls, but did not show any dif…

AdultGenetic MarkersMalePsychosismedicine.medical_specialtyPsychometricsNeurocognitive DisordersNeuropsychological TestsAudiologySocial Environmentbehavioral disciplines and activitiesDevelopmental psychologyWisconsin Card Sorting TestRisk FactorsSchizophrenic PsychologymedicineHumansNeuropsychological assessmentPrefrontal cortexBiological Psychiatrymedicine.diagnostic_testGenetic Carrier ScreeningNeuropsychological testmedicine.diseaseDorsolateral prefrontal cortexPsychiatry and Mental healthmedicine.anatomical_structureSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologySchizophrenia Research
researchProduct

Effects of immunosuppressive drugs on the cognitive functioning of renal transplant recipients: A pilot study

2011

Some renal transplant patients show cognitive, emotional, and behavioral changes as part of possible neurotoxic effects associated with immunosuppressive medication, especially tacrolimus. This study evaluated effects of immunosuppressive drugs on some cognitive tasks. Patients treated with sirolimus and cyclosporine reported some of the noncognitive side effects related to immunosuppressive treatment. We observed attention and working memory impairment in patients treated with sirolimus or tacrolimus. Performance of cyclosporine-treated subjects was similar to that of healthy volunteer controls. Since the mood, anxiety, and sleep patterns measured were unaffected, it could be concluded tha…

AdultGraft RejectionMaleSleep Wake Disordersmedicine.medical_specialtyPilot ProjectsNeuropsychological TestsDevelopmental psychologyYoung AdultSurveys and QuestionnairesInternal medicinemedicineHumansNeuropsychological assessmentCognitive deficitPsychiatric Status Rating ScalesAnalysis of Variancemedicine.diagnostic_testCognitionMiddle AgedKidney TransplantationTacrolimusTransplantationClinical Psychologysurgical procedures operativeMoodNeurologySirolimusQuality of LifeKidney Failure ChronicAnxietyFemaleNeurology (clinical)medicine.symptomCognition DisordersPsychologyImmunosuppressive AgentsFollow-Up Studiesmedicine.drugJournal of Clinical and Experimental Neuropsychology
researchProduct

Longitudinal changes in odor identification performance and neuropsychological measures in aging individuals.

2015

To examine changes in odor identification performance and cognitive measures in healthy aging individuals. While cross-sectional studies reveal associations between odor identification and measures of episodic memory, processing speed, and executive function, longitudinal studies so far have been ambiguous with regard to demonstrating that odor identification may be predictive of decline in cognitive function.One hundred and 7 healthy aging individuals (average age 60.2 years, 71% women) were assessed with an odor identification test and nonolfactory cognitive measures of verbal episodic memory, mental processing speed, executive function, and language 3 times, covering a period of 6.5 year…

AdultMaleAgingMemory Episodic050105 experimental psychology03 medical and health sciencesExecutive Function0302 clinical medicineCognitionmedicineHumans0501 psychology and cognitive sciencesNeuropsychological assessmentLongitudinal StudiesHealthy agingskin and connective tissue diseasesEpisodic memoryAgedmedicine.diagnostic_testmusculoskeletal neural and ocular physiologyOdor discrimination05 social sciencesNeuropsychologyCognitionOdor identificationMiddle AgedNeuropsychology and Physiological PsychologyCross-Sectional StudiesOdorantsLinear ModelsFemalesense organsCognitive Assessment SystemPsychologyCognition Disorderspsychological phenomena and processes030217 neurology & neurosurgeryCognitive psychologyNeuropsychology
researchProduct

Standardization and validation of a parallel form of the verbal and non-verbal recognition memory test in an Italian population sample.

2017

In the neuropsychological assessment of several neurological conditions, recognition memory evaluation is requested. Recognition seems to be more appropriate than recall to study verbal and nonverbal memory, because interferences of psychological and emotional disorders are less relevant in the recognition than they are in recall memory paradigms. In many neurological disorders, longitudinal repeated assessments are needed to monitor the effectiveness of rehabilitation programs or pharmacological treatments on the recovery of memory. In order to contain the practice effect in repeated neuropsychological evaluations, it is necessary the use of parallel forms of the tests. Having two parallel…

AdultMaleDermatologyNeuropsychological TestsVerbal learningVocabulary050105 experimental psychologyRecognition memory03 medical and health sciencesNonverbal communicationYoung Adult0302 clinical medicinemedicineHumans0501 psychology and cognitive sciencesMemory disorderNeuropsychological assessmentMemory assessmentRepeated assessmentRecognition memoryAgedAged 80 and overAnalysis of Variancemedicine.diagnostic_testRecallSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologica05 social sciencesNeuropsychologySettore M-PSI/03 - PsicometriaAge FactorsAssociation LearningReproducibility of ResultsRecognition PsychologyGeneral MedicineMiddle AgedVerbal Learningmedicine.diseaseTest (assessment)Psychiatry and Mental healthItalyParallel formsFemaleNeurology (clinical)Psychology030217 neurology & neurosurgeryCognitive psychologyNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Prenatal exposure to organochlorine compounds and neuropsychological development up to two years of life

2012

Polychlorinated biphenyls (PCB), hexachlorobenzene (HCB), and dichlorodiphenyl dichloroethylene (pp′DDE) are persistent, bioaccumulative, and toxic environmental pollutants with potential neurotoxic effects. Despite a growing body of studies investigating the health effects associated with these compounds, their specific effects on early neuropsychological development remain unclear. We investigated such neuropsychological effects in a population-based birth cohort based in three regions in Spain (Sabadell, Gipuzkoa, and Valencia) derived from the INMA [Environment and Childhood] Project. The main analyses in this report were based on 1391 mother–child pairs with complete information on mat…

AdultMaleDichlorodiphenyl DichloroethylenePopulationNeuropsychological TestsBayley Scales of Infant DevelopmentToxicologychemistry.chemical_compoundPregnancyEnvironmental healthHexachlorobenzeneHydrocarbons ChlorinatedmedicineHumansNeuropsychological assessmenteducationPrenatal exposurelcsh:Environmental sciencesGeneral Environmental SciencePsychomotor learninglcsh:GE1-350education.field_of_studymedicine.diagnostic_testChemistryNeuropsychologyInfantEnvironmental ExposureHexachlorobenzenePolychlorinated BiphenylsChild developmentSpainPrenatal Exposure Delayed EffectsEnvironmental PollutantsFemale
researchProduct

Age at surgery as a predictor of cognitive improvements in patients with drug-resistant temporal epilepsy

2017

Temporal lobe epilepsy (TLE) surgery is an effective procedure that can produce cognitive changes. However, the prognostic factors related with cognitive outcomes need to be better understood. The aim of the present study is to know if age at surgery is a reliable predictor of verbal memory competence and considering factors such as: hemisphere; type of surgery; pre-surgical seizure frequency; and epilepsy duration. Sixty-one typically dominant patients with drug-resistant TLE (34 with left TLE [L-TLE] and 27 with right TLE [R-TLE]) underwent a neuropsychological assessment before and a year after surgery. Results showed that R-TLE patients had better evolution in short- and long-term verba…

AdultMaleDrug Resistant Epilepsymedicine.medical_specialtyMemory Long-TermDrug resistanceNeuropsychological Testsbehavioral disciplines and activitiesTemporal lobeYoung Adult03 medical and health sciencesBehavioral NeuroscienceEpilepsyCognition0302 clinical medicinePredictive Value of TestsmedicineHumansIn patient030212 general & internal medicineNeuropsychological assessmentEffects of sleep deprivation on cognitive performanceMemory Disordersmedicine.diagnostic_testAge FactorsCognitionMiddle Agedmedicine.diseasenervous system diseasesSurgeryMemory Short-TermEpilepsy Temporal Lobenervous systemNeurologyFemaleNeurology (clinical)Verbal memoryPsychologypsychological phenomena and processes030217 neurology & neurosurgeryEpilepsy & Behavior
researchProduct